Skip to main content
. 2022 Oct 21;44(10):5126–5138. doi: 10.3390/cimb44100349

Figure 1.

Figure 1

ICM measurements of the patient’s rectal biopsies before taking a tezacaftor/ivacaftor and ivacaftor. With the introduction of amiloride, there was a decrease in the ΔISC and no response to forskolin/IBMX, and a change in the ΔISC in the negative direction was observed with the addition of carbachol and histamine.